- Home
- IBIO vs PTHL Comparison
IBIO vs PTHL Comparison
Compare IBIO & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- PTHL
- Stock Information
- Founded
- IBIO 2008
- PTHL 1998
- Country
- IBIO United States
- PTHL China
- Employees
- IBIO N/A
- PTHL N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- PTHL
- Sector
- IBIO Health Care
- PTHL
- Exchange
- IBIO Nasdaq
- PTHL Nasdaq
- Market Cap
- IBIO 11.9M
- PTHL 13.5M
- IPO Year
- IBIO N/A
- PTHL 2024
- Fundamental
- Price
- IBIO $0.93
- PTHL $0.88
- Analyst Decision
- IBIO Strong Buy
- PTHL
- Analyst Count
- IBIO 2
- PTHL 0
- Target Price
- IBIO $5.50
- PTHL N/A
- AVG Volume (30 Days)
- IBIO 2.1M
- PTHL 1.8M
- Earning Date
- IBIO 11-11-2025
- PTHL 01-01-0001
- Dividend Yield
- IBIO N/A
- PTHL N/A
- EPS Growth
- IBIO N/A
- PTHL N/A
- EPS
- IBIO N/A
- PTHL N/A
- Revenue
- IBIO $400,000.00
- PTHL $448,196.00
- Revenue This Year
- IBIO N/A
- PTHL N/A
- Revenue Next Year
- IBIO N/A
- PTHL N/A
- P/E Ratio
- IBIO N/A
- PTHL N/A
- Revenue Growth
- IBIO 77.78
- PTHL N/A
- 52 Week Low
- IBIO $0.56
- PTHL $0.51
- 52 Week High
- IBIO $6.89
- PTHL $32.00
- Technical
- Relative Strength Index (RSI)
- IBIO 64.71
- PTHL 29.98
- Support Level
- IBIO $0.77
- PTHL $0.78
- Resistance Level
- IBIO $0.97
- PTHL $0.98
- Average True Range (ATR)
- IBIO 0.07
- PTHL 0.16
- MACD
- IBIO 0.01
- PTHL 0.56
- Stochastic Oscillator
- IBIO 82.62
- PTHL 51.66
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.